Calcium phosphate precipitation

Calcium phosphate precipitation is the physicochemical process by which calcium and phosphate ions combine to form solid mineral deposits, most notably hydroxyapatite [Giachelli, 2004]. Physiologically, this process is fundamental to biomineralization, providing the structural framework for bones and teeth [Shanahan et al., 2011]. However, when this process occurs in non-skeletal tissues, it is termed ectopic or vascular calcification, which is a major complication in atherosclerosis and chronic kidney disease [London et al., 2003]. This pathological mineralization leads to increased arterial stiffness and cardiovascular mortality [Moe & Chen, 2004]. Therapeutic strategies do not target a single receptor but rather aim to modulate the systemic ion product or inhibit crystal nucleation and growth. Common interventions include phosphate binders like sevelamer to reduce intestinal absorption and bisphosphonates that adsorb onto mineral surfaces to prevent further precipitation [Moe & Chen, 2004]. Additionally, calcimimetics like cinacalcet are used to manage secondary hyperparathyroidism, which indirectly influences the mineral balance [Block et al., 2004]. Understanding the regulation of this precipitation is crucial for managing diseases characterized by abnormal mineral metabolism.

Other names

Hydroxyapatite formationEctopic calcificationVascular calcificationBiomineralizationPathological calcification

Drugs typically act by reducing the concentration of constituent ions (calcium and phosphate) in the blood, inhibiting the nucleation and growth of hydroxyapatite crystals, or promoting endogenous inhibitors of calcification [Giachelli, 2004].